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Abstract 
Purpose: To investigate the effect of beam angles and field number on functionally-guided intensity 
modulated radiotherapy (IMRT) normal lung avoidance treatment plans that incorporate 
hyperpolarised helium-3 magnetic resonance imaging (3He-MRI) ventilation data.  
Methods and Materials: Eight non-small cell lung cancer (NSCLC) patients had pre-treatment 3He-
MRI that was registered to inspiration breath-hold radiotherapy planning computed tomography 
(CT). IMRT plans that minimised the volume of total lung receivŝŶŐA? ? ?'Ǉ ?s20) were compared with 
plans that minimised 3He-MRI defined ĨƵŶĐƚŝŽŶĂůůƵŶŐƌĞĐĞŝǀŝŶŐA? ? ?'Ǉ ?fV20). Coplanar IMRT plans 
using 5-field manually optimised beam angles and 9-field equidistant plans were also evaluated. For 
each pair of plans, the Wilcoxon signed ranks test was used to compare fV20 and the percentage of 
planning target volume (PTV) receiving 90% of the prescription dose (PTV90). 
Results: Incorporation of 3He-MRI led to median reductions in fV20 of 1.3% (range: 0.2 - 9.3%; p = 
0.04) and 0.2% (range: 0 to 4.1%; p = 0.012) for 5- and 9-field arrangements, respectively. There was 
no clinically significant difference in target coverage. 
Conclusions: Functionally-guided IMRT plans incorporating hyperpolarised 3He-MRI information can 
reduce the dose received by ventilated lung without comprising PTV coverage. The effect was 
greater for optimised beam angles rather than uniformly spaced fields. 
 
1 Introduction 
1.1 The rationale for functional lung avoidance treatment planning 
Attempts to improve survival rates for lung cancer patients undergoing curative intent treatment 
have focused on novel drug combinations and radiation intensification (Bradley et al 2015). 
However, the clinical benefits of dose escalation may be improved by better identification and 
treatment of the frequently occurring co-morbidities that reduce pre-radiotherapy pulmonary 
function (Marks et al 1995, Seppenwoolde et al 2002, Hoover et al 2014) and currently limit dose 
escalation due to the significant likelihood of radiation induced lung injury (RILI) (Madani et al 2007, 
Robbins et al 2012, Palma et al 2013). Minimisation of RILI risk to healthy, well ventilated and 
perfused lung while maximising the tumour dose is, therefore, a critical balancing act when planning 
radiation treatment.  
 
Pulmonary function tests of the whole lung lack sensitivity to chronic disease (Simon et al 2012) and 
fail to provide the regional information required for functional dose optimisation when treatment 
planning (Marks et al 1993, 1997), whereas 3D imaging of regional pulmonary function can deliver 
the necessary localisation of healthy and defective tissue and aid with the assessment of pulmonary 
co-morbidity. Although single photon emission computed tomography (SPECT) has been the most 
commonly investigated modality for assessing such normal lung avoidance treatment planning, 
alternative techniques using magnetic resonance imaging (MRI) and CT have also received 
considerable attention (Ireland et al 2016). 
1.2 Lung avoidance planning with SPECT 
Initial work using functional data provided by 99mTc-labeled macroaggregated albumin perfusion 
SPECT, in a study of 56 lung cancer patients, demonstrated that functionally adapted radiation 
treatment planning was most useful for cases with small tumours and poor pulmonary function 
(Marks et al 1995). In a later study of 104 lung patients, by the same group at the Duke University 
Medical School, North Carolina, USA, 11% were found to have conventional treatment plans 
modified by inclusion of SPECT data to allow avoidance of functioning lung. These patients had 
extremely poor pre-radiotherapy pulmonary function and inhomogeneous perfusion maps (Munley 
et al 1999).  
 
Others have demonstrated the feasibility of SPECT-guided conformal treatment planning but with 
smaller patient numbers (Cattaneo et al 1999). In a study of 6 patients, who were representative of 
common perfusion defects identified from a study of 116 lung patients at The Netherlands Cancer 
Institute, Amsterdam, functional data only improved an automatic beam weight optimised 
conformal (3D-CRT) treatment plan for a single patient with a very large perfusion defect while there 
were no changes in planning parameters for those with smaller defects (Seppenwoolde et al 2002). 
Radiation was found to only affect small regions of lung when treating small tumours, therefore the 
improvement that could be gained by perfusion-weighted dose optimisation was less significant 
(Seppenwoolde et al 2002). In a related study conducted at The Royal Marsden, Sutton, UK, 
functional SPECT 3D-CRT planning similarly resulted in only one patient with large perfusion defects 
gaining benefit from the functional conformal plan while five with inhomogeneous perfusion did not. 
No additional benefit was gained by using non-coplanar fields (Christian et al 2005).  
 
Further testing of the concept of functionally constrained dose planning became possible with the 
introduction of intensity-modulated radiotherapy (IMRT), since IMRT optimisation must take into 
account the dose distribution in healthy tissue as well as tumours (Bentzen 2005). The Duke 
University team demonstrated in one patient the potential to adapt IMRT planning constraints with 
functional SPECT data to divert dose from high to low perfused regions (Das et al 2004). In further 
studies at Duke University for 5 patients, IMRT plans were compared with and without SPECT 
guidance and functional V20 reduced by an absolute median of 5.2% with 9 beams (McGuire et al 
2006) and 6.1% with 4 beams (McGuire et al 2010). 9 field IMRT was also used to produce a 
significant median reduction in functional V20 (the volume of lung receivŝŶŐA? ? ?'Ǉ ?of 6.8% for a 
group of 16 advanced stage patients at M.D. Anderson Cancer Center, Houston, TX, USA, with the 
degree of reduction tending to be greater in patients with a larger perfusion defect than those who 
had no or small perfusion defect (Shioyama et al 2007). In a separate study at the Royal Marsden, 
UK, 5 field IMRT and 4 field conformal plans were compared for 17 and 25 patients with no 
difference for early stage patients and significant improvements for stage III patients (Lavrenkov et 
al 2007, 2009). Another comparison of 3D conformal planning and IMRT found no advantage for 
either method but inclusion of perfusion SPECT in IMRT demonstrated a 3.2% absolute difference in 
functional V20 from a cohort of 10 patients in Jinan, China (Yin et al 2009). 3 beam IMRT and 
ventilation SPECT data was applied to 10 stage III patients in Ontario, Canada, and was considered 
beneficial when well ventilated lung did not surround the planning target volume (PTV) (Munawar et 
al 2010). A separate Canadian study in Quebec observed small but statistically significant changes 
(median 0.9 Gy) to mean perfusion-weighted lung dose when comparing anatomical and functional 
plans for 15 advanced stage patients but no significant difference was evident for functional V20 (St-
Hilaire et al 2011). More recently, researchers from Jinan, China, constrained 7 field IMRT plans with 
SPECT perfusion data to give a significant absolute functional V20 reduction of 3.1% from 10 stage I-
III patients (Tian et al 2014). 
1.3 Lung avoidance planning with MRI 
Following the work of Lawrence Marks and others using SPECT for functional lung avoidance 
planning, Ireland and colleagues at The University of Sheffield, UK, explored the feasibility of using 
inert gas MRI for treatment planning (Ireland et al 2007) due to its superior spatial and temporal 
resolution (van Beek et al 2004, Stavngaard et al 2005). The incorporation of functional regions 
defined from 3He MRI images into 5 or 7 beam IMRT plans for 6 stage I-III lung cancer patients 
produced a statistically significant 3.1% median reduction of functional V20. However, without large 
study numbers it is difficult to assess which groups of patients may benefit from lung avoidance 
functional planning. Therefore, a follow-on study in Sheffield investigated seven simulated scenarios 
that represented cases of non-small-cell lung cancer (NSCLC) with significant functional lung defects. 
Small but statistically significant reductions in functional V20 (median 2.7%) and mean functional 
lung dose (median 0.4 Gy) were possible when 5 field IMRT planning was supplemented by 
functional information (Bates et al 2009). 
 
Other hyperpolarised gas MRI research centres have also begun investigations into functionally 
weighted radiotherapy lung planning. At the University of Wisconsin, Madison, USA, data from 
separate patients who had undergone inert gas MRI and planning CT was used in a single test case to 
demonstrate the feasibility of creating a helical Tomotherapy plan constrained using ventilated 
volumes defined by hyperpolarised 3He MRI (Hodge et al 2010). Helical Tomotherapy planning was 
also explored by Cai et al at the University of Virginia, Charlottesville, USA, who simulated tumour 
volumes within the CTs of 6 patients (Cai et al 2011) and found a statistically significant 1.9% mean 
reduction in functional V20 and 0.8 Gy for mean functional lung dose. Although treatment plans 
themselves were not altered in a related study on the use of hyperpolarised 3He MRI by a group in 
Massachusetts, USA, many issues such as patient setup, post-treatment ventilation changes and the 
potential for modifying treatment based on functional data are illustrated by 5 case studies (Allen et 
al 2011). In a study of 15 lung patients at the University of Western Ontario, London, Canada , 3He 
MRI identified more cases of pre-existing chronic obstructive pulmonary disease (COPD) than 
previously diagnosed by CT and pulmonary function tests (Mathew et al 2012), which may affect 
choice of treatment as well as providing data for functionally-guided planning. 
1.4 Lung avoidance planning with CT-based surrogate measurements of function 
To avoid the use of SPECT or MRI, methods to derive surrogate functional lung parameters from 
either 4D-CT or breath-hold inhalation and exhalation CT images have been proposed (Guerrero et al 
2005, 2006, Simon et al 2012). The feasibility of including this CT-ďĂƐĞĚ  ?ǀĞŶƚŝůĂƚŝŽŶ ?or tissue 
expansion data into treatment planning has been explored by several groups. An initial study at M.D. 
Anderson Cancer Center, Houston, TX, USA, evaluated the impact of intensity based 4D-CT derived 
ventilation data on 9 beam IMRT plans for 21 stage III lung cancer patients. Although there was no 
significant difference in functional V20, a mean 2.9 Gy reduction in dose to functional lung was 
detected using a 90% threshold for functional tissue definition (Yaremko et al 2007).  
 
The Jacobian CT derived metric of regional volume change was used in a study at Stanford University 
to show statistically significant reductions in mean dose to functional lung of 1.8 Gy for 6 field IMRT 
and 2.0 Gy for volumetric modulated arc therapy (VMAT) for 15 stage I-III patients (Yamamoto et al 
2011). 
 
In a related study, an alternative method of using 4D-CT data to functionally constrain VMAT and 
IMRT plans was attempted with 8 lung cancer patients with COPD at Hiroshima University, Japan 
(Kimura et al 2012). Application of a threshold of - ? ? ? ,h ĚĞĨŝŶĞĚ Ă  ?ůŽǁ ĂƚƚĞŶƵĂƚŝŽŶ ĂƌĞĂ ?  ?> ?
significantly reduced the V20 in functional plans compared with anatomical only plans (mean 1.5% 
for IMRT and mean 1.6% for VMAT) and produced a small but significant reduction in MLD (mean 
0.23 Gy for IMRT, mean 0.5 Gy for VMAT). 
 
Huang et al at the China Medical University Hospital, Taiwan ? ƵƐĞĚ Ă ȴs  ?brute force geometric ?
method to calculate the surrogate measure of ventilation from 4D-CT (Huang et al 2013). Applying 
the method to 11 IMRT plans for stage III patients produced significant reductions of 1.2 Gy for 
mean functional lung dose and 2.6% for functional V20 by modifying gantry angles in the functional 
plans to avoid the highly functional regions. 
1.5 Impact of beam angle and number on lung avoidance treatment planning  
It is important to consider if beam orientation may have an effect on whether the inclusion of 
functional volumes has a significant impact on planning. For example, in a study of 16 stage III-IV 
lung cancer patients at Guangzhou Medical University, China, the inclusion of a Jacobian measure of 
function derived from 4D-CT into plans with 5 equally spaced beams resulted in a statistically 
significant mean reduction of 5.2% for functional V20. However, when beams angles were optimised 
there was no longer a significant difference between anatomical and functional plans (Wang et al 
2014).  
 The impact of 4D-CT derived Jacobian data on lung avoidance, for 11 patients with small tumour 
volumes who were eligible for stereotactic ablative radiotherapy (SABR), was investigated at Tohoku 
University, Sendai, Japan (Kadoya et al 2015). Conformal treatment with 7-9 beams that were 
automatically determined by beam angle optimisation gave a 3.2% reduction (not statistically 
significant, t test, p=0.093) in functional V20 when a 90% thresholded functional region was used 
during planning. 
 
In a comprehensive study to compare IMRT plans generated by inclusion of CT ventilation and SPECT 
ventilation data, Kida et al used 9 equally spaced beams and varied only the lung weight 
(importance) factor map (Kida et al 2016). A selection of 8 patients was taken from a larger 18 
patient study that had shown low correlation between spatial overlap of defects seen on CT and 
SPECT ventilation images (Yamamoto et al 2014) and the correlation between the CT and SPECT 
weight factor maps was similarly low. Several patients showed little difference between the 
functional image-based and anatomic image-based plans, a common feature of several previous 
functional lung avoidance studies (Seppenwoolde et al 2002, Christian et al 2005). 
 
Greater knowledge of the impact of beam arrangement and field number would be beneficial when 
incorporating functional information into treatment planning. Therefore, the aim of this study was, 
for the first time, to use ventilation data from 3He-MRI to investigate the impact of beam 
arrangement for functionally-guided lung avoidance IMRT plans.  
 
2 Methods and Materials  
2.1 Patient characteristics 
Ten NSCLC patients due to undergo radical radiotherapy were recruited to a research ethics 
committee approved prospective study. Patients gave written informed consent to undergo 
inspiration breath-hold CT and 3He-MRI prior to treatment. 
2.2  Image acquisition and registration 
Inspiration breath-hold CT scans were acquired at 512 × 512 pixels with 2.5 mm slice thickness and 
0.98 mm pixel size (GE Healthcare, Princeton, NJ, USA). Images were acquired while patients were in 
the conventional supine position with arms raised above the head. Patients performed a 530 ms 
breath-hold via a room air filled 1L Tedlar bag (Jensen Inert Products, Coral Springs, FL, USA) to 
replicate the subsequent functional lung imaging procedure. 
 
On the same day, patients underwent hyperpolarised 3He-MR ventilation imaging on a 1.5 T whole 
body Eclipse scanner (Philips Medical Systems, Cleveland, OH, USA), fitted with a transmit-receive 
coil tuned to 48.5 MHz and an additional radiofrequency amplifier (2 kW, Analogic Corporation, 
Peabody, MA, USA). A volume coil (De Zanche et al 2008) allowed 3He-MR images to be obtained in 
the treatment position, which is supine with arms up. A 3D gradient echo pulse sequence was 
employed (Wild et al 2005). Patients were imaged during a 16s inspiration breath-hold upon 
inhalation from a 1L Tedlar bag consisting of a mixture of equal amounts of 3He gas (Spectra Gases, 
Huntingdon, UK) and N2. Spin exchange optical pumping was used to hyperpolarize the 
3He gas to 
30% (GE Healthcare, Princeton, NJ, USA). 
 
The 3He-MR and inspiration CT images were then imported into the Eclipse treatment planning 
system (TPS) (Varian Medical Systems, Palo Alto, CA, USA) for registration via the rigid control point 
tool (Ireland et al 2008, Tahir et al 2014).  
2.3 Target volume definition 
The breath-hold CT images were contoured in the Eclipse TPS. A gross tumour volume (GTV) was 
delineated for each patient. As per local protocol, a uniform margin of 5 mm was then added to the 
GTV to create the clinical target volume (CTV). This was further expanded by 15 mm craniocaudally 
and 10 mm axially to produce the planning target volume (PTV). The PTV of one the patients partially 
intersected with the spinal cord and thus the CTV-to-PTV margin was modified to 5 mm in that 
region. In addition, whole lung, spinal cord, oesophagus and heart structures were contoured. A 
normal tissue avoidance structure was defined by subtracting the PTV from the external body 
contour. Functional lung was segmented using a threshold defined as the mean plus three standard 
deviations of the background values of the 3He-MR images.  
2.4 IMRT Planning 
Inverse planning was performed using the Dose-Volume-Optimiser module of the Eclipse TPS. The 
final forward dose calculation was performed using ĐůŝƉƐĞ ?Ɛ ŶŝƐŽƚƌŽƉŝĐ ŶĂůǇƚŝĐ ůŐŽƌŝƚŚŵ  ? ? 
which accounts for lateral scatter and inhomogeneities (Bragg et al 2008). The dose and 
fractionation scheme employed was based on continuous hyperfractionated accelerated 
radiotherapy (CHART), which is 54 Gy in 36 fractions (Saunders et al 1997). 
 
For each patient, four dynamic IMRT plans using coplanar 6 MV beams were generated with the aim 
of minimising the volume of either ƚŽƚĂůůƵŶŐƌĞĐĞŝǀŝŶŐA? ? ?'Ǉ ?s20 ?ŽƌĨƵŶĐƚŝŽŶĂůůƵŶŐƌĞĐĞŝǀŝŶŐA? ? ?
Gy (fV20). Two of the four plans were designed with 5-fields, with beam angles manually optimised. 
For clinical acceptability, each plan was designed to meet the dosimetric requirements described in 
Table 1. Plans were then optimised by interactively adjusting constraints and objectives during 
inverse planning with relative priorities in the following order; maximizing target coverage, 
minimizing spinal cord dose, reducing dose to total or functional lung and limiting normal tissue dose 
(Bates et al 2009). To remove the subjectivity in beam angle optimisation, this process was repeated 
for two equidistant 9-field plans (Shioyama et al 2007). All plans were normalised such that the 
mean dose received by the PTV was 54 Gy. No patients were treated with the IMRT plans. 
2.5 Plan evaluation 
Plans were evaluated by the following dosimetric parameters:  
x V10  ?ƉĞƌĐĞŶƚĂŐĞŽĨƚŽƚĂůůƵŶŐƌĞĐĞŝǀŝŶŐA? ? ?'Ǉ)  
x fV10  ?ƉĞƌĐĞŶƚĂŐĞŽĨĨƵŶĐƚŝŽŶĂůůƵŶŐƌĞĐĞŝǀŝŶŐA? ? ?'Ǉ)  
x V20  ?ƉĞƌĐĞŶƚĂŐĞŽĨƚŽƚĂůůƵŶŐƌĞĐĞŝǀŝŶŐA? ? ?'Ǉ)  
x fV20 (percentage of functional lung receiǀŝŶŐA? ? ?'Ǉ)  
x MLD (mean total lung dose in Gy)  
x fMLD (mean functional lung dose in Gy)  
x PTV90 (the percent PTV volume receiving 90% of the prescription dose).  
 
To determine the best plan, a plan quality index defined as the ratio of PTV90:fV20 was used where a 
higher value may permit dose escalation to the tumour while sparing of functional lung (Lavrenkov 
Table 1. Intensity-modulated radiotherapy (IMRT) planning requirements. 
PTV Mean dose 54 Gy; 95% of PTV receiving at least 
90% of the prescribed dose 
TL or FL sŽůƵŵĞƌĞĐĞŝǀŝŶŐA? ? ?'ǇŶŽŵŽƌĞƚŚĂŶ ? ?A?
Spinal cord DĂǆŝŵƵŵĚŽƐĞA? ? ?'Ǉ 
Oesophagus Volume receiviŶŐA? ? ?'ǇŶŽŵŽƌĞƚŚĂŶ ? ?A?
Heart sŽůƵŵĞƌĞĐĞŝǀŝŶŐA? ? ?'ǇŶŽŵŽƌĞƚŚĂŶ ? ?A?
Normal tissue DĂǆŝŵƵŵĚŽƐĞA? ? ?'Ǉ 
Abbreviations. PTV, planning target volume; TL, total lung; FL, functional lung. 
et al 2007). In addition, the total number of monitor units (MUs) generated by each plan was 
recorded. 
2.6 Statistical analysis 
Statistical significance (p < 0.05) of differences between the four plans was assessed by the Wilcoxon 
signed rank test. Statistical analysis was performed using SPSS version 15.0 for Windows (SPSS, 
Chicago, IL, USA). 
3 Results 
3.1 Patient characteristics 
Seven male and three female NSCLC patients (median age 75, range 58-80 years) underwent 3He-
MRI and breath-hold CT prior to radiotherapy. One patient had insufficient intake of 3He gas to 
produce a viable ventilation image and for one patient, radical radiotherapy was not possible due to 
an excessively large PTV. Therefore, image data from eight patients was available for treatment 
planning evaluation (Table 2). As defined by the 3He-MRI, the median functional lung as a 
percentage of total lung was 77% (range 65-95%). Representative registered CT and 3He-MR images 
are shown in Figure 1. 
 
Table 2. Non-small cell lung cancer patient characteristics. 
Patient Stage 
 
Tumour 
Location 
PTV Volume 
(cm3) 
Total Lung 
Volume 
(cm3) 
Functional 
Lung Volume 
(cm3) 
Functional 
Lung (as % of 
Total lung) 
1 T4N0 Left upper lobe 769.6 4569.2 3270.5 71.6 
2 T2N2 Left upper lobe 543.5 5409.1 3677.9 68.0 
3 T3N1 Left lower lobe 308.7 4309.0 3850.9 89.4 
4 T4Nx Left mid-
upper lobe 830.3 8461.9 5459.7 64.5 
5 T2N0 
Left upper 
lobe 204.0 4219.0 4008.6 95.0 
6 T1N0 Left mid lung 76.5 5117.4 3990.1 78.0 
7 T2N1 Left upper lobe 1128.5 4481.0 3748.5 83.7 
8 T2N0 Right mid lung 362.6 4730.1 3571.9 75.5 
 
3.2 Plan evaluation 
The functional lung, normal lung and PTV dose-volume histograms for the 5- and 9-field 
anatomically- and functionally-guided plans are displayed in Figure 2 for patient 2. Dosimetric 
parameters for all patients for the 5- and 9-field anatomically- and functionally-guided plans are 
displayed in Tables 3 and 4, respectively. To test whether 5 beams with manual beam angle 
optimisation could provide dosimetrically favourable plans to 9 equidistant beams, the plans that 
incorporated functional information for both are compared in Table 5. For the anatomical 9-field 
plan, the V20 of patient 7 was 35.7% and thus exceeded the planning constraint of 35%. Apart from 
this, all planning objectives and constraints pertaining to target coverage and critical structures were 
met. 
 
For the 5-field plans, the median reduction in fV20 and fMLD when incorporating functional 
information was 1.3% (range: -0.2 to 9.3%; p = 0.04) and 0.2 Gy (range: 0 to 1.3 Gy; p = 0.03), 
respectively. For the 9-field arrangements, the median reduction of these parameters was 0.2% 
(range: 0 to 4.1%; p = 0.012) and 0.1 Gy (range: 0 to 0.3 Gy; p = 0.012), respectively. Comparing 
these parameters between the 5- and 9-field plans which incorporated functional information, the 
median differences between them were 2.7% (range: -5.7 to 5.2%; p = 0.263) and 1.3 Gy (range: -2.3 
to 3.5 Gy; p = 0.161), respectively, both in favour of 5 fields. 
 
Although there was no statistically significant difference in the PTV90 between the two 5-field plans, 
a marginal difference was observed between the two 9-field plans (0.1%; range: 0 to 0.9%; p = 0.012) 
but was not considered to be clinically significant. A larger difference in PTV90 was demonstrated 
between the 5- and 9-field functionally-guided plans, in favour of 9-fields (0.9%; range: 0.2 to 2.5%;  
p = 0.012). Comparison of the plan quality index between the 5- and 9-field functional plans 
demonstrated no significant difference. However, a greater total number of MUs were generated by 
the 9-field plans (median 627 MUs, range 473 - 1245 vs. 590 MUs, range 369 - 806; p = 0.036).  
 
  
Figure 2. The functional lung (green), normal lung (red) and PTV (blue) dose-volume histograms for the 5- and 9-field anatomically- and 
functionally-guided plans for patient 2. Compared with the 5-field anatomically guided plan, the 5-field functionally guided plan, 
exhibits marked functional lung sparing with no detriment to PTV coverage. Conversely, the 9-field functionally guided exhibits only 
marginal functional lung sparing compared with its anatomically guided counterpart.  
 Table 3. Comparison of dose/volume parameters for 5-field anatomically (A) and functionally (B) guided IMRT plans. 
Patient 
V10 f V10 V20 f V20 MLD fMLD PTV90 PTV90:f V 20 
A B A B A B A B A B A B A B A B 
1 28.8 28.4 25.6 25.5 11.7 11.4 11.4 11.1 8.2 8.0 8.1 7.9 99.7 99.6 8.8 9.0 
2 28.6 29.7 29.0 29.5 19.2 13.6 20.3 11.0 9.6 9.2 9.8 8.8 99.0 99.0 4.9 9.0 
3 42.1 42.1 43.3 43.3 21.4 21.5 21.3 21.2 11.5 11.5 11.5 11.5 98.3 98.3 4.6 4.6 
4 21.1 21.2 25.9 25.9 11.7 11.1 13.5 11.1 7.3 7.2 8.5 8.4 96.9 96.0 7.2 8.7 
5 15.6 15.7 15.6 15.8 7.9 8.2 7.9 8.1 5.1 5.2 5.1 5.1 96.5 97.0 12.2 12.0 
6 10.8 10.7 10.1 9.9 5.3 5.2 4.5 4.4 4.5 4.5 4.1 4.1 97.6 97.7 21.7 22.2 
7 49.5 43.9 46.0 40.4 31.2 26.2 27.9 23.5 14.1 12.8 13.2 11.9 99.1 97.4 3.6 4.2 
8 19.4 20.6 21.5 21.7 11.3 9.3 13.0 10.1 7.6 7.4 8.1 7.6 97.1 95.1 7.5 9.4 
Median 
difference 
-0.02 0.03 0.45 1.33 0.15 0.16 0.05 -0.55 
Wilcoxon p  0.89 0.78 0.05 0.04 0.04 0.03 0.33 0.04 
 
Abbreviations: V10 (percentage of total lung ƌĞĐĞŝǀŝŶŐ A?  ? ? 'Ǉ ?fV10  ?ƉĞƌĐĞŶƚĂŐĞ ŽĨ ĨƵŶĐƚŝŽŶĂů ůƵŶŐ ƌĞĐĞŝǀŝŶŐ A?  ? ? 'Ǉ ? s20 
 ?ƉĞƌĐĞŶƚĂŐĞŽĨƚŽƚĂůůƵŶŐƌĞĐĞŝǀŝŶŐA? ? ?'Ǉ ?fV20  ?ƉĞƌĐĞŶƚĂŐĞŽĨĨƵŶĐƚŝŽŶĂůůƵŶŐƌĞĐĞŝǀŝŶŐA? ? ?'Ǉ ?D> ?ŵĞĂŶƚŽƚĂůůƵŶŐĚŽƐĞ
in Gy); fMLD (mean functional lung dose in Gy); PTV90 (the percent PTV volume receiving 90% of the prescription dose). 
 
 Table 4. Comparison of dose/volume parameters for 9-field anatomically (C) and functionally (D) guided IMRT plans. 
Patient 
V10 f V10 V20 f V20 MLD fMLD PTV90 PTV90:f V 20 
C D C D C D C D C D C D C D C D 
1 39.0 38.3 37.7 37.3 17.3 15.9 18.0 16.2 10.1 9.9 9.9 9.7 99.8 99.7 5.6 6.2 
2 41.5 40.6 42.7 41.8 15.7 15.0 17.6 16.7 11.0 10.7 11.5 11.1 99.6 99.4 5.7 6.0 
3 50.6 50.6 51.6 51.6 17.8 17.7 17.7 17.5 12.0 12.0 12.1 12.0 98.8 98.5 5.6 5.6 
4 19.6 19.6 18.2 18.1 6.4 6.4 5.8 5.8 5.4 5.4 4.9 4.9 98.5 98.4 16.9 16.9 
5 22.6 22.6 22.9 22.8 9.0 9.0 8.9 8.9 5.8 5.8 5.8 5.8 98.2 98.1 11.0 11.1 
6 19.6 19.6 18.2 18.1 6.4 6.4 5.8 5.8 5.4 5.4 4.9 4.9 98.4 98.4 16.8 16.9 
7 51.5 50.6 48.3 47.6 35.7 31.5 32.0 27.9 15.0 14.6 14.1 13.7 99.5 98.7 3.1 3.5 
8 35.0 34.8 35.3 35.2 12.7 12.6 14.4 14.2 9.3 9.2 9.5 9.5 97.7 97.5 6.8 6.9 
Median 
Difference 
0.16 0.12 0.12 0.19 0.03 0.06 0.10 -0.07 
Wilcoxon p 0.04 0.01 0.03 0.01 0.07 0.01 0.01 0.01 
 
Table 5 
Summary of dose/volume parameters for 5-field (B) - 9-field (D) functionally guided IMRT 
 V10 f V10 V20 f V20 MLD fMLD PTV90 PTV90:f V 20 
Median 
Difference 
-8.68 -8.24 -1.28 -2.73 -1.19 -1.32 -0.92 1.72 
Wilcoxon p 0.02 0.04 0.40 0.26 0.09 0.16 0.01 0.33 
 
4 Discussion 
4.1 IMRT planning 
This study compared manually optimised 5-field IMRT plans and fixed equidistant 9-field 
arrangements, both with and without the incorporation of functional information defined by 3He-
MRI. Although the use of fewer fields are often preferred in clinical practice (Liu et al 2006), 9-field 
equidistant plans were also designed to remove subjectivity in selection of beam angles (Shioyama 
et al 2007) in order to investigate how effective the inverse planning algorithm is at avoiding 
functional lung. 
 
When explicitly accounting for functional lung, a statistically significant median reduction in fV20 was 
demonstrated for the 5-field manually optimised plans (1.3%; p = 0.04). In contrast, only a modest 
reduction was observed for 9-fields (0.2%; p = 0.012). This suggests that beam angle optimisation is a 
more important factor than the inverse planning algorithm, by itself, in reducing the dose to 
functional lung. This is consistent with related studies that have demonstrated improved sparing of 
critical structures using fewer fields, optimised according to the geometry of the target and critical 
structures, than with uniformly spaced beams (Stein et al 1997, Liu et al 2006, Popple et al 2007). 
 
Significantly higher V10 values were observed for the 9-field plans which can be attributed to the 
increased  “low-dose ďĂƚŚ ? ĞĨĨĞĐƚ (Plowman et al 2008), where low-dose regions are more spread 
out as a consequence of using a greater number of fields (Bragg et al 2002). This caveat could be 
clinically relevant as V10 may be a better predictor of radiation pneumonitis than V20 (Schallenkamp 
et al 2007), and is consistent with Popple et al (2007) who showed that fewer fields, generating less 
MUs, reduce the dose received by organs-at-risk (OARs) due to a decrease in multileaf collimator 
leakage and transmission (Popple et al 2007). This is also demonstrated by the reduction in MUs 
generated by 5- fields in the present study. 
 
The V10 and V20 results differ with those reported by Liu et al (2006), who did not show any 
significant differences in V10 and V20 between 5-, 7- and 9-field IMRT plans (Liu et al 2006). This could 
be due to the use of the step-and-shoot technique which requires less MUs compared to the sliding 
window mode used in the current study. As a consequence, critical structures receive less indirect 
dose from inter- and intraleaf transmission (Jothybasu et al 2009). 
 
For the functionally-guided plans, all OAR tolerances including the spinal cord, heart and oesophagus 
were met. In addition, improvements in the fV20 and fMLD were without detriment to the PTV 
coverage, suggesting that functionally-guided IMRT can achieve clinically acceptable plans while 
preferentially sparing functional lung. An improvement in PTV90 was observed for 9-fields over 5-
fields (0.9%; p = 0.012). This is in keeping with previous investigations which demonstrate that an 
increased number of fields provide enhanced target volume coverage and homogeneity (Popple et al 
2007). Stein et al (1997) found that conformity of prescription dose to the tumour increased with 
increasing field number but at the cost of increased dose received by OARs (Stein et al 1997). If 
functionally-guided IMRT was to be applied in practice, a clinical decision would need to be made 
whether small improvements such as 0.9% in conformity can outweigh the benefits of increased 
functional avoidance in addition to the reduction in manpower constraints when using fewer fields. 
 
One disadvantage of using fewer fields was a greater occurrence of hot spots in normal tissue. In 
order to mitigate this effect, it was necessary to fine tune beam angles and edit the fluence of 
individual beams. This required more time to plan than the uniformly spaced 9-field plans which 
required only a single optimisation to produce acceptable plans. However, this additional time 
requirement for 5-fields could be dependent on the TPS and thus not necessarily true for other 
commercial systems. 
 
The highest median reduction in fV20 of 1.3% is lower than that reported in several previous 3He-
MRI, SPECT and CT-based functionally-guided IMRT studies (McGuire et al 2006, Shioyama et al 
2007, Ireland et al 2007, Bates et al 2009, Wang et al 2014, Yamamoto et al 2016). This may be due 
to the different methods used to segment the functional lung volume or other methodological 
differences (Ireland et al 2016). It has been suggested that a greater degree of functional defects will 
lead to larger reductions in fV20 (Seppenwoolde et al 2002, Bates et al 2009). In the present study, 
the largest individual reductions demonstrated were 2.4  W 9.3%, shown by patients 2, 4, 7 and 8. The 
location of ventilation defect in relation to target volume was an important factor in reducing fV20. 
For example, patient 2, who had the largest reduction of fV20, had large functional defects in 
proximity to the target volume. In contrast, patient 1 had relatively large defects spanning across 
approximately 30% of the total lung while no significant reduction in fV20 was observed. When 
optimizing solely based on anatomical information for this patient, only a small proportion of 
functional lung was in the pathway of the beams and thus no significant differences were observed 
compared with the functionally-guided IMRT plan. 
 
Although patients 3 and 4 did not show any significant differences between 9-field anatomically- and 
functionally-guided plans, it was perhaps surprising that reductions of 3.7 and 5.3% respectively in 
fV20 were observed when compared with the 5-field arrangement. Patient 3 had a large centrally 
located tumour and so more equally spaced beam angles would be preferred in this situation. In 
addition, each of the 5 fields would have a larger contribution to meeting the prescription dose and 
this could explain why 9-fields were able to achieve improvements in functional lung dose. 
 
The clinical significance on patient outcome and long term survival will require further investigation 
but the goal of lung avoidance planning is in line with the aspiration to lower the non-cancerous lung 
dose as far as possible. 
4.2 Study limitations 
As with many other related studies, one limitation of this study is that it uses lung ventilation data 
alone. Both ventilation and perfusion would be preferable for the full assessment of lung function 
(Yuan et al 2011, Ireland et al 2016). 
 
The inhalation CT images used in this study were acquired at functional residual capacity (FRC) + 1L 
in order to match the 3He MRI breathing manoeuvre, which provides significant improvements in CT 
and 3He MRI image registration (Ireland et al 2008) and improved lung sparing compared to 
expiration breath-hold (Tahir et al 2010). Therefore, the breathing manoeuvre may have led to some 
of the observed discrepancies from other studies. In addition, hyperpolarised gas MRI (Halaweish et 
al 2013) and CT ventilation (Mistry et al 2013) have been shown to be sensitive to inflation state. 
Due to limited temporal resolution, the majority of previous nuclear medicine based studies 
employed tidal breathing acquisitions for functional image acquisition. The differences in breathing 
manoeuvre would inevitably give rise to differences in defect volumes and dosimetric parameters 
compared with the present study. 
5 Conclusion 
Functionally-guided IMRT plans incorporating hyperpolarised 3He-MRI information accurately 
registered to inspiration CT can reduce the dose received by ventilated lung without comprising 
tumour coverage. The selection of optimal beam angles can have a greater impact on these 
differences than uniformly spaced field arrangements. 
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